Treatment and diagnostics neuroblastoma in Seoul, South Korea

Neuroblastoma – is a malignant tumor consisting of immature cells of the sympathetic nervous system, which can be localized in different organs and tissues. It occurs mainly in children and can regress independently, however, in rare cases. Neuroblastoma treatment in Seoul is carried out by authoritative and competent oncologists with a rich experience in solving such problems. The prognosis of therapy in local clinics is favorable in 70-90% of cases even with late detection of the neoplasm.

Drawing up a personal therapeutic plan begins with a thorough differential diagnosis. For this, oncologists and radiologists use the following methods:

• laboratory determination of specific tumor markers using unique reagents,
• plain radiography on digital equipment,
• CT and MRI on extra-class wide-field tomographs,
• PET and PET-CT,
• radiological scintigraphy with contrast,
• aspiration and trephine biopsy of the bone marrow,
• biopsy of foci of presumptive metastasis,
• cytogenetic examination.

When treating neuroblastoma in Seoul, the following procedures may be applied:

1. chemical therapy with new-generation cytostatic drugs,
2. radiation therapy,
3. nuclear medicine methods (radioactive iodine treatment, MIBG therapy, etc.),
4. stereotactic surgical interventions under the control of robotic and neuronavigation systems.

At the end of the treatment process, a rehabilitation program is developed, allowing the child to recover faster and better, as well as to avoid side effects of the procedures. Parents are given recommendations on preventing relapses and strengthening the baby''s health.